|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Genocea Biosciences, Inc. (GNCA) |
|
|
$0.59 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
51,640,000 |
| Market
Cap: |
30.69(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.5943 - $0.5943 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer immunotherapies using its proprietary ATLAS™ platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. GEN-011 is an investigational solid tumor cell therapy candidate comprised of CD4+ and CD8+ neoantigen-targeted peripheral T cells. GEN-011 is comprised of T cells extracted from the patient's peripheral blood and specific for ATLAS-prioritized neoantigens. GEN-009 is an investigational neoantigen vaccine delivering adjuvanted synthetic long peptides from ATLAS-identified neoantigens.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
93,582,981 |
| Total Sell Value |
$0 |
$0 |
$0 |
$6,768,648 |
| Total People Sold |
0 |
0 |
0 |
15 |
| Total Sell Transactions |
0 |
0 |
0 |
27 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Giannasca Paul |
VP of Development |
• – – |
2014-08-27 |
4 |
OE |
$2.86 |
$3,727 |
D/D |
1,303 |
1,303 |
|
- |
|
| Hetherington Seth V |
Chief Medical Officer |
• – – |
2014-08-18 |
4 |
OE |
$2.02 |
$22,220 |
D/D |
11,000 |
11,000 |
|
- |
|
| Polaris Venture Partners Special Founders Fund V, |
10% Owner |
– – • |
2014-08-14 |
4 |
S |
$13.01 |
$87,883 |
I/I |
(6,755) |
2,055,228 |
|
- |
|
| Polaris Venture Partners Special Founders Fund V, |
10% Owner |
– – • |
2014-08-13 |
4 |
S |
$13.00 |
$37,765 |
I/I |
(2,905) |
2,061,983 |
|
- |
|
| Polaris Venture Partners Special Founders Fund V, |
10% Owner |
– – • |
2014-08-12 |
4 |
S |
$13.03 |
$273,500 |
I/I |
(20,990) |
2,064,888 |
|
- |
|
| Polaris Venture Partners Special Founders Fund V, |
10% Owner |
– – • |
2014-08-11 |
4 |
S |
$13.24 |
$18,907 |
I/I |
(1,428) |
2,085,878 |
|
- |
|
| Polaris Venture Partners Special Founders Fund V, |
10% Owner |
– – • |
2014-08-08 |
4 |
S |
$13.41 |
$554,852 |
I/I |
(41,376) |
2,087,306 |
|
- |
|
182 Records found
|
|
Page 8 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
